Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 71-80 of 93 for

Edit search filters
  1. A Study of Financial Burden of Medical Therapy in Patients with Pulmonary Arterial Hypertension (PAH)

    Jacksonville, FL

  2. A Study to Form a Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

    Rochester, MN

  3. Pulmonary Hypertension Association Registry (PHAR)

    Jacksonville, FL

  4. A Study of the Effect of Sildenafil for Improvement of Hepatic Fibrosis after the Fontan Heart Surgery

    Rochester, MN

  5. A Study to Identify the Molecular Basis of Pulmonary Vascular Disease and to Discover Biological Measurements of the Disease and Therapeutic Responses

    Rochester, MN

  6. A Study to Establish a Registry for the Pulmonary Hypertension Association

    Jacksonville, FL

  7. In Situ Measurement of Anti-Apoptotic Phenotype in the Pulmonary Arterial Endothelium and Its Association with Pre-Capillary Disease in Pulmonary Hypertension

    Rochester, MN

  8. A Study to Assess Frailty and Its Impact on Patients with Pulmonary Hypertension

    Rochester, MN

  9. A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)

    Rochester, MN, Jacksonville, FL

  10. Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies

    Jacksonville, FL

.

Mayo Clinic Footer